Previous Close | 30.50 |
Open | 30.50 |
Bid | 39.60 |
Ask | 42.50 |
Strike | 200.00 |
Expire Date | 2024-12-20 |
Day's Range | 30.50 - 30.50 |
Contract Range | N/A |
Volume | |
Open Interest | 3 |
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.